4//SEC Filing
Omrix Biopharmaceuticals, Inc. 4
Accession 0001209191-07-039446
CIK 0001349426operating
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 2:13 PM ET
Size
7.2 KB
Accession
0001209191-07-039446
Insider Transaction Report
Form 4
Horowitz Bernard
Director
Transactions
- Exercise/Conversion
Common Stock
2007-06-29$12.27/sh+2,750$33,743→ 8,467 total - Exercise/Conversion
Stock Option
2007-06-29−2,750→ 8,250 totalExercise: $12.27From: 2007-06-27Exp: 2016-06-27→ Common Stock (2,750 underlying)
Documents
Issuer
Omrix Biopharmaceuticals, Inc.
CIK 0001349426
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001349426
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 2:13 PM ET
- Size
- 7.2 KB